Beauty Health Co
For the period ended Dec 31, 2025. Filed Mar 12, 2026.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed Mar 12, 2026
SKIN$15.94-4.9%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 8. Consolidated Statements of Cash Flows
CONSOLIDATED STATEMENTS OF CASH FLOWS
(in thousands)
| Year Ended December 31, | |||
|---|---|---|---|
| 2025 | 2024 | 2023 | |
| Cash flows from operating activities: | |||
| Net loss | $(9,519) | $(29,098) | $(100,116) |
| Adjustments to reconcile net loss to net cash from operating activities | |||
| Share-based compensation | 14,824 | 26,696 | 22,544 |
| Amortization of intangible assets | 16,988 | 19,537 | 20,907 |
| Depreciation of property and equipment | 3,848 | 9,940 | 11,332 |
| Amortization of other assets | 4,513 | 4,203 | 2,436 |
| Amortization of debt issuance costs | 3,636 | 3,319 | 4,229 |
| Inventory write-down | 7,219 | 28,041 | 18,272 |
| Syndeo inventory write-down | — | — | 19,568 |
| Provision for estimated credit losses | 2,067 | 5,134 | 5,153 |
| Change in fair value of warrant liabilities | (487) | (3,067) | (11,919) |
| Gain on exchange and repurchases of convertible senior notes, net | (18,089) | (33,411) | — |
| Deferred income taxes | 2,219 | (3,748) | (1,079) |
| Other, net | (107) | 15,981 | 7,067 |
| Changes in operating assets and liabilities: | |||
| Accounts receivable | 5,162 | 20,804 | 16,520 |
| Inventories | 15,792 | (10,500) | (22,617) |
| Prepaid expenses, other current assets, and income tax receivable | 3,423 | 15,479 | (6,951) |
| Accounts payable, accrued expenses, and income tax payable | (7,179) | (43,776) | 44,001 |
| Other, net | (6,825) | (9,400) | (7,597) |
| Net cash provided by operating activities | 37,485 | 16,134 | 21,750 |
| Cash flows from investing activities: | |||
| Cash paid for intangible assets | (4,860) | (6,038) | (9,224) |
| Cash paid for property and equipment | (303) | (756) | (3,825) |
| Cash paid for asset acquisitions | — | — | (18,458) |
| Net cash used for investing activities | (5,163) | (6,794) | (31,507) |
| Cash flows from financing activities: | |||
| Repurchase of 2026 Notes in connection with exchange | (392,583) | — | — |
| Issuance of 2028 Notes in connection with exchange, net | 237,601 | — | — |
| Repurchase of 2026 Notes | (18,372) | (156,082) | — |
| Payment of tax withholdings on vested stock awards | (1,572) | (1,957) | (3,234) |
| Repurchase of common stock | — | — | (30,155) |
| Payment of accelerated share repurchases | — | — | (2,240) |
| Payment of contingent considerations related to acquisitions | — | — | (1,819) |
| Other, net | — | (302) | — |
| Net cash used for financing activities | (174,926) | (158,341) | (37,448) |
| Net change in cash, cash equivalents, and restricted cash | (142,604) | (149,001) | (47,205) |
| Effect of foreign currency translation on cash | 5,214 | (3,961) | 2,033 |
| Cash, cash equivalents, and restricted cash beginning of period | 370,063 | 523,025 | 568,197 |
| Cash, cash equivalents, and restricted cash end of period | $232,673 | $370,063 | $523,025 |
| Supplemental disclosures of cash flow information and non-cash investing activities: | |||
| Cash paid for interest | $14,440 | $8,014 | $9,375 |
| Class A Common Stock issued for asset acquisition | — | — | 1,310 |
The accompanying notes are an integral part of these consolidated financial statements
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.